Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
Background Long-term aspirin prevents vascular events but is only modestly effective. Rivaroxaban alone or in combination with aspirin might be more effective than aspirin alone for vascular prevention in patients with stable coronary artery disease (CAD) or peripheral artery disease (PAD). Rivaroxa...
Published in: | Canadian Journal of Cardiology |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Pulsus Group Inc.
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026258046&doi=10.1016%2fj.cjca.2017.06.001&partnerID=40&md5=23d00519f29c96c7468bdcfef2dd3b67 |